Biondvax Pharmaceuticals OverviewBiondvax Pharmaceuticals Net Income
Profitability analysis for BVXV.
Quarterly Net Income
-$3.76M
↑ 68.84% YoY
As of Jun 2023
Annual Net Income (TTM)
$7.78M
↑ 118.85% YoY
Trailing 12 months ending Jun 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...